PT-141 10mg
Melanocortin Receptor and Molecular Signaling Research
Chemical Information:
- Molecular Formula: C₅₀H₆₈N₁₄O₁₀
- Molecular Weight: Approximately 1025.18 g/mol
- Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
- Compound Type: Synthetic cyclic heptapeptide research compound
- Structural Note: PT-141, also known scientifically as bremelanotide, is a synthetic cyclic peptide derived from melanocortin-related peptide research. Its structure incorporates N-terminal acetylation, a norleucine residue, D-phenylalanine, and peptide cyclization. Confirm compound identity, sequence, purity, and analytical characteristics against the applicable Certificate of Analysis and batch documentation.
$49.00
Availability: 29 in stock
PT-141 is a synthetic cyclic research peptide supplied in lyophilized form for qualified laboratory and analytical investigation. This material is intended exclusively for controlled in vitro studies involving melanocortin receptor interactions, molecular signaling, peptide characterization, and receptor-based assay development. Its defined cyclic structure makes it suitable for comparative investigation of peptide conformation, receptor-associated molecular behavior, stability, and biochemical interactions under carefully controlled experimental conditions. This material is supplied strictly for research use only and is not intended for human or veterinary administration, clinical application, diagnosis, treatment, or therapeutic use.
Product Designation Note:
PT-141 is a research designation associated with bremelanotide, a cyclic melanocortin receptor-active peptide. Although bremelanotide also exists as an FDA-approved prescription drug in a specific finished pharmaceutical formulation, research-grade PT-141 supplied for laboratory investigation is not represented as that approved drug product and must not be marketed, labeled, or used as a substitute for it.Research Applications:
In controlled non-human laboratory environments, PT-141 may be utilized for investigation of:- In vitro interaction studies involving melanocortin receptor-associated systems
- Comparative evaluation of cyclic peptide receptor-binding characteristics
- Peptide conformation, structural integrity, and stability analysis
- Molecular signaling and receptor-based analytical assay development
Storage and Handling:
- Store lyophilized research material at approximately -20°C under controlled laboratory conditions.
- Following laboratory reconstitution, maintain at 2-8°C according to validated experimental procedures.
- Minimize unnecessary temperature fluctuations and repeated freeze-thaw exposure.
- Use appropriate aseptic laboratory practices and protect the material from moisture, contamination, and excessive light.
Product Specifications:
- Purity: ≥99% when verified by the applicable HPLC analytical report or Certificate of Analysis
- Appearance: Lyophilized white to off-white powder
- Solubility: Soluble in suitable laboratory-grade solvents or buffers according to experimental requirements
Compliance Notice:
PT-141 is supplied FOR RESEARCH USE ONLY as a laboratory and analytical research material. It is intended exclusively for in vitro, biochemical, molecular, receptor-interaction, peptide-characterization, and controlled experimental investigation. Research-grade PT-141 is not represented as an FDA-approved finished pharmaceutical product and is not intended for human or veterinary use, clinical administration, diagnosis, treatment, cure, prevention, or mitigation of any disease or condition. No therapeutic, sexual-health, hormonal, performance, behavioral, or other health-related claims are made for this research material. Buyers are responsible for ensuring that acquisition, possession, storage, handling, and laboratory use comply with all applicable federal, state, and local requirements.Related Products
